Suppression of Antitumor Immunity by IL-10 and TGF-β-Producing T Cells Infiltrating the Growing Tumor: Influence of Tumor Environment on the Induction of CD4+ and CD8+ Regulatory T Cells1
暂无分享,去创建一个
[1] J. Xiang,et al. CD4−8− Dendritic Cells Prime CD4+ T Regulatory 1 Cells to Suppress Antitumor Immunity1 , 2005, The Journal of Immunology.
[2] T. Curiel,et al. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. , 2005, Cancer research.
[3] M. Huang,et al. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. , 2005, Cancer research.
[4] A. Rudensky,et al. TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells , 2005, The Journal of experimental medicine.
[5] K. Mills,et al. Regulatory T cells: friend or foe in immunity to infection? , 2004, Nature Reviews Immunology.
[6] G. Berry,et al. Induction of T helper type 1–like regulatory cells that express Foxp3 and protect against airway hyper-reactivity , 2004, Nature Immunology.
[7] George Coukos,et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.
[8] R. Dummer,et al. Immune activation status of CD8+ T cells infiltrating non-small cell lung cancer. , 2004, Lung cancer.
[9] P. V. van Eeden,et al. Timed Ablation of Regulatory CD4+ T Cells Can Prevent Murine AIDS Progression , 2004, The Journal of Immunology.
[10] B. Rouse,et al. CD4+CD25+ Regulatory T Cells Control the Severity of Viral Immunoinflammatory Lesions1 , 2004, The Journal of Immunology.
[11] P. Allen,et al. Pulmonary Tumors Inefficiently Prime Tumor-Specific T Cells1 , 2004, The Journal of Immunology.
[12] J. Prieto,et al. CD4+/CD25+ Regulatory Cells Inhibit Activation of Tumor-Primed CD4+ T Cells with IFN-γ-Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination 1 , 2003, The Journal of Immunology.
[13] Rui Li,et al. Analysis of the immunological microenvironment at the tumor site in patients with non-small cell lung cancer , 2003, Langenbeck's Archives of Surgery.
[14] O. Leavy,et al. Cholera Toxin Promotes the Induction of Regulatory T Cells Specific for Bystander Antigens by Modulating Dendritic Cell Activation 1 , 2003, The Journal of Immunology.
[15] M. Steurer,et al. Increase of regulatory T cells in the peripheral blood of cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] T. Elliott,et al. Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens , 2002, European journal of immunology.
[17] J. Simecka,et al. Depletion of CD8+ T Cells Exacerbates CD4+ Th Cell-Associated Inflammatory Lesions During Murine Mycoplasma Respiratory Disease1 , 2002, The Journal of Immunology.
[18] Lloyd J. Old,et al. The roles of IFNγ in protection against tumor development and cancer immunoediting , 2002 .
[19] K. Mills,et al. Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells , 2002, The Journal of experimental medicine.
[20] T. Tüting,et al. Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma. , 2001, Cancer research.
[21] D. Umetsu,et al. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen , 2001, Nature Immunology.
[22] G. Coukos,et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. , 2001, Cancer research.
[23] G. Beatty,et al. IFN-γ-Dependent Inhibition of Tumor Angiogenesis by Tumor-Infiltrating CD4+ T Cells Requires Tumor Responsiveness to IFN-γ1 , 2001, The Journal of Immunology.
[24] S. Sakaguchi. Regulatory T cells , 2000, Cell.
[25] R. Coffman,et al. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells , 1996, The Journal of experimental medicine.
[26] H. Okada,et al. Escape of malaria parasites from host immunity requires CD4+CD25+ regulatory T cells , 2004, Nature Medicine.
[27] I. Melero,et al. CD4 /CD25 Regulatory Cells Inhibit Activation of Tumor-Primed CD4 T Cells with IFN- -Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination , 2003 .